Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy

被引:407
作者
Baglio, Serena Rubina [1 ,2 ]
Pegtel, D. Michiel [2 ]
Baldini, Nicola [1 ]
机构
[1] Ist Ortoped Rizzoli, Lab Orthopaed Pathophysiol & Regenerat Med, Bologna, Italy
[2] VU Univ Med, Canc Ctr Amsterdam, Dept Pathol, NL-1081 HV Amsterdam, Netherlands
来源
FRONTIERS IN PHYSIOLOGY | 2012年 / 3卷
关键词
mesenchymal stem cell (MSC); microvesicles; exosomes; regenerative medicine; therapy;
D O I
10.3389/fphys.2012.00359
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Mesenchymal stem cells (MSCs) are adult multipotent cells that give rise to various cell types of the mesodermal germ layer. MSCs are of great interest in the field of regenerative medicine and cancer therapy because of their unique ability to home to damaged and cancerous tissue. These cells also regulate the immune response and contribute to reparative processes in different pathological conditions, including musculoskeletal and cardiovascular diseases. The use of MSCs for tissue repair was initially based on the hypothesis that these cells home to and differentiate within the injured tissue into specialized cells. However, it now appears that only a small proportion of transplanted MSCs actually integrate and survive in host tissues. Thus, the predominant mechanism by which MSCs participate in tissue repair seems to be related to their paracrine activity. Indeed, MSCs provide the microenvironment with a multitude of trophic and survival signals including growth factors and cytokines. Recent discoveries suggest that lipid microvesicles released by MSCs may also be important in the physiological function of these cells. Over the past few years the biological relevance of micro- and nano-vesicles released by cells in intercellular communication has been established. Alongside the conventional mediators of cell secretome, these sophisticated nanovesicles transfer proteins, lipids and, most importantly, various forms of RNAs to neighboring cells, thereby mediating a variety of biological responses. The physiological role of MSC derived vesicles (MSC-MVs) is currently not well understood. Nevertheless, encouraging results indicate that MSC-MVs have similar protective and reparative properties as their cellular counterparts in tissue repair and possibly anti-cancer therapy. Thus, MSC-MVs represent a promising opportunity to develop novel cell free therapy approaches that might overcome the obstacles and risks associated with the use of native or engineered stem cells.
引用
收藏
页数:11
相关论文
共 117 条
  • [1] Human mesenchymal stem cells modulate allogeneic immune cell responses
    Aggarwal, S
    Pittenger, MF
    [J]. BLOOD, 2005, 105 (04) : 1815 - 1822
  • [2] Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR
    Al-Nedawi, Khalid
    Meehan, Brian
    Kerbel, Robert S.
    Allison, Anthony C.
    Rak, Janusz
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) : 3794 - 3799
  • [3] Circulating Plastic Adherent Mesenchymal Stem Cells in Aged Hip Fracture Patients
    Alm, Jessica J.
    Koivu, Helka M. A.
    Heino, Terhi J.
    Hentunen, Teuvo A.
    Laitinen, Saara
    Aro, Hannu T.
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 2010, 28 (12) : 1634 - 1642
  • [4] Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
    Alvarez-Erviti, Lydia
    Seow, Yiqi
    Yin, HaiFang
    Betts, Corinne
    Lakhal, Samira
    Wood, Matthew J. A.
    [J]. NATURE BIOTECHNOLOGY, 2011, 29 (04) : 341 - U179
  • [5] Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness
    Beyth, S
    Borovsky, Z
    Mevorach, D
    Liebergall, M
    Gazit, Z
    Aslan, H
    Galun, E
    Rachmilewitz, J
    [J]. BLOOD, 2005, 105 (05) : 2214 - 2219
  • [6] Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines
    Birnbaum, Tobias
    Roider, Julia
    Schankin, Christoph J.
    Padovan, Claudio S.
    Schichor, Christian
    Goldbrunner, Roland
    Straube, Andreas
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2007, 83 (03) : 241 - 247
  • [7] Osteoprogenitor cells within skeletal muscle
    Bosch, P
    Musgrave, DS
    Lee, JY
    Cummins, J
    Shuler, F
    Ghivizzani, SC
    Evans, C
    Robbins, PD
    Huard, J
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 2000, 18 (06) : 933 - 944
  • [8] Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts
    Brune, Jan C.
    Tormin, Ariane
    Johansson, Maria C.
    Rissler, Pehr
    Brosjo, Otte
    Lofvenberg, Richard
    von Steyern, Fredrik Vult
    Mertens, Fredrik
    Rydholm, Anders
    Scheding, Stefan
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (02) : 319 - 330
  • [9] Bruno S., 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0033115
  • [10] LEUKOCYTE-ENDOTHELIAL CELL RECOGNITION - 3 (OR MORE) STEPS TO SPECIFICITY AND DIVERSITY
    BUTCHER, EC
    [J]. CELL, 1991, 67 (06) : 1033 - 1036